6550--Notice of Intent to Sole Source Point of Care (POC) Glucose Hospital Meter System (CPT)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Department of Veterans Affairs Network Contracting Office NCO2, representing the VISN2 South Medical Centers, intends to award a firm fixed price, sole source contract to Nova Biomedical Corporation for the supply of Point of Care (POC) Glucose Hospital Meter Systems with Cost Per Test (CPT) services. This contract covers several VA medical centers across New York and New Jersey, including locations in the Bronx, East Orange, Wappingers Falls, Brooklyn, New York City, and Northport. The required system must be FDA approved and CLIA waived for all patient types, including critically ill patients, and include meters, reagents, controls, and necessary peripherals to ensure proper glucose testing via fingerstick methods. After conducting market research in compliance with relevant federal acquisition regulations, it was concluded that Nova Biomedical is the sole vendor able to meet the requirements of this complex medical testing system. This sole source justification was based on the absence of any alternative suppliers capable of fulfilling the full scope of this need. The contract prohibits the use of gray market items, emphasizing authorized distribution only. While this notice is not a request for quotes, capability statements may be submitted for consideration by June 18, 2026, after which the government may proceed without competition at its discretion. The contracting officer managing this action is Lindsay Goldsmith, and the contract is designated under solicitation number 36C24226Q0674.
General Info
Agency
NAICS
Place of Performance
NYSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
This is a notice of intent to award a sole source contract and is not a request for quotes. The Department of Veterans Affairs (DVA) Network Contracting Office NCO2, on behalf of VISN2 South Medical Centers, intends to award a Firm Fixed Price (FFP), sole source action to: Name of Contractor: Nova Biomedical Corp Street Address: 200 Prospect Street City, State, Zip: Waltham, Massachusetts 02453-3457
The following DVA VISN2 south medical centers have a recurring requirement for Point of Care (POC) Glucose Hospital Meter Systems for Cost Per Test (CPT) services:
James J. Peters VA Medical Center (526) 130 W Kingsbridge Rd, Bronx, NY 10468-3904
East Orange VA Medical Center (561) 385 Tremont Avenue, East Orange, NJ 07018-1023
Castle Point VA Medical Center (620) 41 Castle Point Rd., Wappingers Falls, NY 12590-7004
Brooklyn VA Medical Center (630) 800 Poly Place, Brooklyn, NY 11209-7104
Margaret Cochran VA Medical Center (630) 423 East 23rd Street, New York, NY 10010-5011
Northport VA Medical Center (632) 79 Middleville Road, Building 200,Northport, NY 11768-2200
This requirement for fulfillment is defined as a system that is U.S. Food & Drug Administration (FDA) approved and Clinical Laboratory Improvement Amendments (CLIA) of 1988 waived for all patient types (including critically ill). This system is inclusive of meters, reagents, standards, controls, other items required for proper operation of testing meters as well as peripherals necessary for the generation of fingerstick glucose cost per test (CPT) services.
Item James J. Peters East Orange Castle Point Brooklyn Margaret Cochran Northport Glucose Hospital Meter 65 66 46 50 41 50 Docking Stations 65 66 46 50 41 50 Carrying Case 65 66 46 50 41 50 Glucose Strips (1800/case) 44 76 9 38 29 37 Control Solution 1 300 450 100 320 200 180 Control Solution 3 300 450 100 320 200 180 Linearity Kit 10 5 4 3 4 2 Test Vol 78,127 136,800 16,000 67,798 50,604 65,112
Market research was conducted in accordance with Part 10 of the Revolutionary FAR Overhaul (RFO), reviewing the offerings and capabilities available through the current marketplace. In accordance with FAR Part 6.103-1(b), it has been determined that only one source is reasonably capable of fulfilling this action as required. Nova Biomedical Corporation is the sole vendor capable of meeting the requirement by offering an FDA approved, CLIA waived Glucose Hospital System available for use on all patient types.
Market research failed to produce additional sources capable of fulfilling this requirement as a whole. In accordance with the Revolutionary FAR Overhaul (RFO) this notice of intent to sole source with justification to limit competition, satisfies the public posting requirements of 6.301. Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels. This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on June 18, 2026. Responses to be submitted to Lindsay Goldsmith, Contracting Officer at lindsay.goldsmith@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.